Second consensus of the chilean society of endocrinology and diabetes about insulin resistance [II Consenso de la sociedad chilena de endocrinología y diabetes sobre resistencia a la insulina]
Autor
Pollak F.
Araya V.
Lanas A.
Sapunar J.
Arrese M.
Aylwin C.G.
Bezanilla C.G.
Carrasco E.
Carrasco F.
Codner E.
Díaz E.
Durruty P.
Galgani J.
García H.
Lahsen R.
Liberman C.
López G.
Maíz A.
Mujica V.
Poniachik J.
Sir T.
Soto N.
Valderas J.
Villaseca P.
Zavala C.
Resumen
Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people. © 2015 Sociedad Medica de Santiago. All Rights Reserved.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Review
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia (2020)
Folch J.; Olloquequi J.; Ettcheto M.; Busquets O.; Sánchez-López E.; Cano A.; Espinosa-Jiménez T.; García M.L.; Beas-Zarate C.; Casadesús G.; ... (Frontiers Media S.A., 2019) -
Article
The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia (2020)
Folch J.; Ettcheto M.; Busquets O.; Sánchez-López E.; Castro-Torres R.D.; Verdaguer E.; Manzine P.R.; Poor S.R.; García M.L.; Olloquequi J.; ... (MDPI AG, 2018) -
Review
A metabolic perspective of late onset Alzheimer's disease (2020)
Ettcheto M.; Cano A.; Busquets O.; Manzine P.R.; Sánchez-López E.; Castro-Torres R.D.; Beas-Zarate C.; Verdaguer E.; García M.L.; Olloquequi J.; ... (Academic Press, 2019)